Based on the increased numbers of VE cells in the cixutumumab-treated tumours (Fig. 3) and the essential role of angiogenesis in the metastatic pathway30, we hypothesized that tumour angiogenesis could have contributed to the observed level of metastasis during the IGF-1R blockade. This evidence concerns the gene IGF1R and neoplasm.